Replies to post #83608 on Avid Bioservices Inc (CDMO)

[biopharm]

I've received some comments about my evaluation....

I was simply taking price to earnings x 10 to place a value...

Avastin was a good comparison which brought in 6 Billion Yearly

I even brought that down to 5 Billion x 10 = 50 Billion and even reduced that in half to 25 Billion since this is pre-phase III

25 Billion divided by ... just increase OS from 104M to 110M to give some room for more selling and we get 25B / 110M = $227

Now... I believe much more can be added here... but a quick estimate of $227 is not far fetched at all in my opinion.